Volume 9 (2011): Issue 1 (Jan 2011)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
Erratum
Pages: xxiv
Oncology Research Program
Pages: xxvi–xxvii
Beaten at the Alamo by the Europeans
By: Harold J. Burstein
Pages: 1
Ovarian Cancer Guidelines: Treatment Progress and Controversies
By: Robert J. Morgan Jr.
Pages: 4–5
Lessons From ASH 2010: A Focus on NHL
By: Andrew D. Zelenetz
Pages: 7–11
Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer
By: Robin K. Kelley, Stephanie L. Van Bebber, Kathryn A. Phillips, and Alan P. Venook
Pages: 13–25
Myelodysplastic Syndromes
By: Peter L. Greenberg, Eyal Attar, John M. Bennett, Clara D. Bloomfield, Carlos M. De Castro, H. Joachim Deeg, James M. Foran, Karin Gaensler, Guillermo Garcia-Manero, Steven D. Gore, David Head, Rami Komrokji, Lori J. Maness, Michael Millenson, Stephen D. Nimer, Margaret R. O'Donnell, Mark A. Schroeder, Paul J. Shami, Richard M. Stone, James E. Thompson, and Peter Westervelt
Pages: 30–56
Epidemiology, Natural History, and Practice Patterns of Patients with Myelodysplastic Syndromes in 2010
By: Mikkael A. Sekeres
Pages: 57–63
The Role of Iron Chelation Therapy for Patients With Myelodysplastic Syndromes
By: David P. Steensma
Pages: 65–75
Epithelial Ovarian Cancer
By: Robert J. Morgan Jr., Ronald D. Alvarez, Deborah K. Armstrong, Barry Boston, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David Gershenson, Heidi J. Gray, Perry W. Grigsby, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Steven W. Remmenga, Paul Sabbatini, Russell J. Schilder, Julian C. Schink, Nelson Teng, and Theresa L. Werner
Pages: 82–113
Point: Chemosensitivity Assays Have a Role in the Management of Recurrent Ovarian Cancer
By: Julian C. Schink and Larry J. Copeland
Pages: 115–120
Counterpoint: Chemosensitivity Assays for Recurrent Ovarian Cancer
By: Maurie Markman
Pages: 121–124
Indications for Minimally Invasive Surgery for Ovarian Cancer
By: Ernest S. Han and Mark Wakabayashi
Pages: 126–132
  • Collapse
  • Expand